Tatsuya Tai

Dr. Tatsuya Tai

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
TTTatsuya Tai
Tatsuya Tai
TYTakaaki Yamamoto
Takaaki Yamamoto
KYKazunori Yamaguchi
Kazunori Yamaguchi
MWMasahiro Watanabe
Masahiro Watanabe
HTHiroaki Tanaka
Hiroaki Tanaka
SKShinji Kosaka
Shinji Kosaka

14 October 2025 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
TTTatsuya Tai
Tatsuya Tai
TMTakahiro Motoki
Takahiro Motoki
MWMasahiro Watanabe
Masahiro Watanabe
NKNaohiro Kurokawa
Naohiro Kurokawa
SYSayaka Yamashita
Sayaka Yamashita
SKShinji Kosaka
Shinji Kosaka
Objective: This study aimed to evaluate the impact of a pharmacist-led support system on the administration rate of vancomycin (VCM) loading dose, 0–24-hour area under the concentration–time curve (AUC0–24), incidence of acute kidney injury (AKI), and all-cause mortality in hospitalized patients. Design: This retrospective study with interrupted time series analysis was conducted from January 2021 to May 2024. Setting: A public tertiary referral center providing acute and specialized inpatient care in Japan. Patients: Among the 587 hospitalized patients who received VCM during the study period, 326 were evaluated. Intervention: The intervention comprised implementation of a pharmacist-led support system involving prospective prescription review and direct intervention when a VCM loading dose (25–30 mg/kg) was not prescribed. Results: The loading dose administration rate increased significantly by 43.2% immediately introducing the support system (95% confidence interval: 8.40–77.90; P = 0.0156), without significant trend change thereafter. AUC0–24 also increased significantly (241.0 vs 307.0; P < 0.001); there were no significant differences in AKI incidence or 90-day mortality. Conclusions: The support system improved the loading dose administration rate and AUC0–24 without significantly increasing AKI or mortality. The improvement was immediate and sustained over 122 weeks, supporting its use in institutions aiming to optimize VCM loading doses where evidence remains limited.

1 July 2022 in YAKUGAKU ZASSHI
Verified
Journal Article
Closed access
PDF file
TTTatsuya Tai
Tatsuya Tai
KYKazunori Yamaguchi
Kazunori Yamaguchi
NKNaohiro Kurokawa
Naohiro Kurokawa
WSWataru Shinmura
Wataru Shinmura
AMAki Matsubara
Aki Matsubara
SKShinji Kosaka
Shinji Kosaka
We report a haemodialysis patient with end-stage renal failure whom a pharmacist aided in the management of acyclovir (ACV) encephalopathy, which may have been related to valacyclovir hydrochloride (VACV) administered without sufficient dose reduction. The patient 78 years was admitted with a tentative diagnosis of varicella zoster viral meningitis. A pharmacist suspected ACV encephalopathy related to excessive VACV administration and raised a query with the attending physician. According to the pharmacist's proposal, ACV administration was discontinued and continuous hemodiafiltration (CHDF) was performed. On day 5 of hospitalisation, the consciousness disorder was improved. In this report, we showed the detailed CHDF conditions of the present case, and the contribution of a pharmacist to treating and avoiding ACV encephalopathy was discussed.

19 March 2024 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
TTTatsuya Tai
Tatsuya Tai
TMTakahiro Motoki
Takahiro Motoki
KYKazunori Yamaguchi
Kazunori Yamaguchi
MWMasahiro Watanabe
Masahiro Watanabe
TITaichi Ito
Taichi Ito
TDTeruki Dainichi
Teruki Dainichi
Antimicrobial-product package inserts and insufficient staffing impede routine carbapenem monitoring in the inpatient setting in Japan. The collaboration between antimicrobial stewardship teams and clinical pharmacists was associated with a sustained improvement in carbapenem dosing optimization. Our findings could be of use to countries with inadequate monitoring of carbapenem antimicrobial use.

10 June 2020 in Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Verified
Journal Article
Open access
PDF file
TTTatsuya Tai
Tatsuya Tai
KYKazunori Yamaguchi
Kazunori Yamaguchi
MWMasahiro Watanabe
Masahiro Watanabe
TITatsuya Inoue
Tatsuya Inoue
TMTakahiro Motoki
Takahiro Motoki
HHHitoshi Hochi
Hitoshi Hochi
To evaluate changes in the efficacy and safety of antimicrobial therapy through de-escalation improved by the antimicrobial stewardship (AS) activities, which started from 2013 in Kagawa University Hospital, we analyzed changes in the de-escalation rate and the patient outcomes. The number of carbapenem-treated cases evaluated as ‘improper use’ had decreased from 2013 to 2017. In most of these cases, improper use of blood culture was indicated. The AS team directed the proper use of carbapenem through weekly rounds, focusing on “intervention and feedback” according to the guideline. This activity was performed with emphasis on the appropriate use of blood culture results and the process of target therapy. As a result, it was shown that the number of blood culture orders and the rates of hospitalized cases, for which multiple sets of blood cultures were ordered, were increased. Also, the de-escalation rate of blood culture-positive cases treated with carbapenem was improved from 13.1% in 2011 to 29.9% in 2017. Furthermore, as a patient outcome, the 90-day mortality rate was decreased from 24.3% in 2011 to 15.6% in 2017. Similarly, the recurrent bloodstream infections rate was decreased from 5.6% to 0%. On the other hand, in 2011 vs 2017, there was no significant difference in the detection rate of resistant bacteria. Taken together, most of the changes in the indicators related to patient outcome analyzed in the present study suggest that AS activities improved the de-escalation rate, and that the de-escalation contributed to the efficacy and safety of antimicrobial therapy.

16 June 2022 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
TTTatsuya Tai
Tatsuya Tai
KYKazunori Yamaguchi
Kazunori Yamaguchi
MWMasahiro Watanabe
Masahiro Watanabe
HTHiroaki Tanaka
Hiroaki Tanaka
TOTomoya Okazaki
Tomoya Okazaki
SKShinji Kosaka
Shinji Kosaka
What Is Known and Objective In this study, changes in patient outcomes were analysed to evaluate the effects of prospective audit and feedback (PAF), which was promoted under a new system of antimicrobial stewardship (AS), in patients with gram-negative rod (GNR)-positive blood cultures. Methods This study included patients with positive blood cultures treated at Kagawa University Hospital between 2019 and 2020. The effects of PAF, as promoted in 2020 and performed within a few days of treatment initiation, were examined in terms of patient prognosis and estimated cost of extra hospital stay associated with GNR infection. Results and Discussion As AS activities under the new system, proposals were made for targeted therapy based on susceptibility results and for the duration of antimicrobial therapy, escalation and dose increases, and imaging evaluation. Between 2019 and 2020, there was no difference in the rate of de-escalation in the form of switching to a narrower-spectrum intravenous antimicrobial, the rate of image inspection, but the rate of switching to oral therapy after receiving culture results increased from 19.7% to 31.3%, the rate of sensitivity-based treatment increased from 76.4% to 92.2%. Regarding patient outcomes, the 90-day mortality rate and the duration of hospital stay were similar between the groups. The rate of recurrent bloodstream infections decreased from 8.7% to 0.9%. What Is New and Conclusion Most of the changes in the indicators related to patient outcomes analysed in this study suggest that the increased use of PAF in AS activities improved patient outcomes.